Is It Too Late To Consider Synopsys (SNPS) After Its Recent Share Price Rebound?

• If you are trying to figure out whether Synopsys at around US$510 a share looks expensive or interesting, starting with a clear view of its valuation can help you decide where it fits in your watchlist.
• The stock has seen mixed returns, with a 10.2% gain over the last 30 days and a 6.4% gain year to date, but a 3.5% decline over the past year against a backdrop of a 46.3% return over 3 years and 92.0% over 5 years.
• Recent attention on Synopsys has largely centered on its role in software and tools that support chip design, as investors weigh how this exposure fits into their view of the broader semiconductor and software space. Ongoing coverage of the company in market commentary has kept its long term growth story and risk profile in focus for many readers following the sector.
• On Simply Wall St's valuation checks, Synopsys currently scores 0 out of 6, as shown in its valuation score. Next, we look at what the main valuation methods say about that price tag and why an extra lens at the end of this article can give you a clearer view of what the number really means.

Synopsys scores just 0/6 on our valuation checks. See what other red flags we found in the full valuation breakdown.

Approach 1: Synopsys Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model takes estimates of the cash a company could generate in the future and discounts those amounts back into today’s dollars, aiming to arrive at an intrinsic value per share.

For Synopsys, the model uses its last twelve months Free Cash Flow of about $1.33b as a starting point and then builds out cash flow projections. Analyst inputs are available up to 2028, with Simply Wall St extrapolating further out to 2035 under its 2 Stage Free Cash Flow to Equity approach. In this framework, projected Free Cash Flow for 2035 is $5.88b, with intermediate years such as 2026, 2027 and 2028 sitting between $1.91b and $3.21b based on the data provided.

Bringing all of those future cash flows back to today, the model arrives at an estimated intrinsic value of about $375.15 per share, compared with a current share price around $510. That gap implies the stock is about 36.2% above the DCF estimate, which suggests a relatively full price for investors who rely primarily on cash flow based valuation.

Result: OVERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Synopsys may be overvalued by 36.2%. Discover 872 undervalued stocks or create your own screener to find better value opportunities.

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Synopsys.

Approach 2: Synopsys Price vs Earnings

For profitable companies, the P/E ratio is a useful way to think about how much you are paying for each dollar of earnings. This makes it a straightforward tool for comparing familiar names across the same sector.

What counts as a "normal" P/E depends a lot on how quickly earnings are expected to grow and how risky those earnings are. Higher expected growth and lower perceived risk usually justify a higher P/E, while slower growth or higher risk often points to a lower one.

Synopsys currently trades on a P/E of about 73.17x. That sits well above the Software industry average of 30.88x and also higher than the peer group average of 44.89x. Simply Wall St’s Fair Ratio for Synopsys is 41.83x. This Fair Ratio is a proprietary estimate of what the P/E could be based on factors such as earnings growth, industry, profit margins, market cap and risk profile.

Because the Fair Ratio pulls these company specific inputs together, it can be more tailored than a simple peer or industry comparison. Setting the current P/E of 73.17x against the Fair Ratio of 41.83x indicates that the shares are pricing in a richer multiple than that model implies.

Result: OVERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Discover 1446 companies where insiders are betting big on explosive growth.

Upgrade Your Decision Making: Choose your Synopsys Narrative

Earlier we mentioned that there is an even better way to understand valuation, so let us introduce you to Narratives. This is a simple way to connect your view of Synopsys to the numbers you see on screen.

A Narrative is your story about the company, where you set your own assumptions for fair value, future revenue, earnings and margins, instead of only relying on a single model output.

On Simply Wall St, Narratives sit inside the Community page. They link that story to a financial forecast and then to a fair value that you can compare directly with the current Synopsys share price to help you think about whether it looks attractive or stretched based on your own view.

Narratives on the platform update automatically when new information such as earnings releases or news arrives. For Synopsys you might see one investor using cautious revenue and margin assumptions to reach a fair value well below US$510, while another uses more optimistic estimates that place fair value comfortably above the current price.

Do you think there's more to the story for Synopsys? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com